Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Nondepolarizing Paralytics(Archived)

Ryan S. D'Souza  1 , Burdett R. Porter, Rebecca L. Johnson
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Nondepolarizing Paralytics(Archived)

Ryan S. D'Souza et al.
Free Books & Documents

Excerpt

It is necessary to prevent spontaneous muscular contraction and movement when performing surgical procedures. The introduction of muscle relaxants has revolutionized the practice of anesthesia. By the end of the 1950s, non-depolarizing, neuromuscular blocking drugs (NMBDs), d-tubocurarine, and gallamine were available. Although these two relaxants are no longer in use, several newer NMBDs have emerged with safer side effect profiles over the last 20 years. Non-depolarizing muscle relaxants comprise the majority of clinically relevant neuromuscular blockers. As their name indicates, they cause neuromuscular blockade without depolarizing the motor endplate.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Ryan D'Souza declares no relevant financial relationships with ineligible companies.

Disclosure: Burdett Porter declares no relevant financial relationships with ineligible companies.

Disclosure: Rebecca Johnson declares no relevant financial relationships with ineligible companies.

References

    1. Raghavendra T. Neuromuscular blocking drugs: discovery and development. J R Soc Med. 2002 Jul;95(7):363-7. - PMC - PubMed
    1. Sparr HJ, Beaufort TM, Fuchs-Buder T. Newer neuromuscular blocking agents: how do they compare with established agents? Drugs. 2001;61(7):919-42. - PubMed
    1. Bufler J, Wilhelm R, Parnas H, Franke C, Dudel J. Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine. J Physiol. 1996 Aug 15;495 ( Pt 1)(Pt 1):83-95. - PMC - PubMed
    1. Fagerlund MJ, Eriksson LI. Current concepts in neuromuscular transmission. Br J Anaesth. 2009 Jul;103(1):108-14. - PubMed
    1. Martyn JA, Fagerlund MJ, Eriksson LI. Basic principles of neuromuscular transmission. Anaesthesia. 2009 Mar;64 Suppl 1:1-9. - PubMed

Publication types

LinkOut - more resources